John A Stalfort III insider trades

Open-market stock purchases and sales by John A Stalfort III, Director at Acumen Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 30, 2021.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +103%.

Recent trades

DateStockTradeValue
Jun 3, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jun 3, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jun 1, 2026TSHA Taysha Gene Therapies, IncBought (not open market)—
Jun 1, 2026TSHA Taysha Gene Therapies, IncBought (not open market)—

Companies traded

  • ABOS Acumen Pharmaceuticals, Inc: 1 buy, last Jun 3, 2026
  • TSHA Taysha Gene Therapies, Inc: 1 buy, last Jun 1, 2026
  • VRCA Verrica Pharmaceuticals Inc: 3 buys, last Nov 26, 2024

Get free alerts when John A Stalfort III files a new trade →